KEGG: seg:SG4184
Fumarate reductase is an essential enzyme for anaerobic respiration in bacteria, catalyzing the reduction of fumarate to succinate. This process allows Salmonella to generate energy in oxygen-limited environments, which is particularly important during host infection. The enzyme consists of four subunits (frdA, frdB, frdC, and frdD) encoded by the frdABCD operon.
The frdC subunit is a 15 kDa hydrophobic protein that functions as part of the membrane anchor for the complex . It contains transmembrane domains that integrate into the bacterial membrane, allowing the catalytic subunits to function properly. In Salmonella gallinarum, fumarate reductase enables survival in oxygen-limited environments encountered during infection, contributing significantly to virulence and pathogenesis .
The standard methodology for producing recombinant frdC protein involves:
Gene Cloning: The frdC gene is amplified from Salmonella gallinarum genomic DNA and inserted into an expression vector.
Host Selection: E. coli is the most commonly used expression host due to its efficiency and scalability .
Vector Design: Expression vectors typically include:
An inducible promoter system
A purification tag (commonly His-tag) fused to the N-terminus
Appropriate selection markers for transformant identification
Expression Conditions:
Induction at mid-log phase (OD600 ~0.6-0.8)
Temperature optimization (typically 25-37°C)
Duration of expression (4-24 hours)
Purification Process:
Cell lysis (sonication or mechanical disruption)
Membrane fraction isolation
Solubilization with detergents
Affinity chromatography using the His-tag
Concentration and buffer exchange
The final product is often lyophilized with preservatives like trehalose (6%) and stored at -20°C to -80°C to maintain stability . Researchers typically reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL with 5-50% glycerol for long-term storage .
Fumarate reductase significantly enhances Salmonella gallinarum virulence through multiple mechanisms:
Anaerobic Energy Generation: Enables bacterial survival in oxygen-limited environments within host tissues by catalyzing the final step in anaerobic respiration with fumarate as terminal electron acceptor .
Enhanced Tissue Colonization: Supports the metabolic needs of Salmonella during colonization, aiding its proliferation and persistence in the host.
Immune Evasion: Helps bacteria persist within immune cells, such as macrophages, where oxygen is limited.
Systemic Spread: Facilitates survival in multiple organs during the systemic phase of fowl typhoid infection.
Research has demonstrated that mutations in anaerobic respiration genes, including those affecting fumarate reductase (frdA), result in attenuated virulence in chicken models. In particular, studies showed that mutations in the frdA gene contributed to reduced mortality rates in chickens challenged with mutant strains compared to wild-type S. gallinarum .
Several expression systems are utilized for recombinant frdC production, each with specific advantages:
The selection criteria should include:
Required protein yield
Downstream application needs
Purification strategy
Folding requirements
Most commercial sources utilize E. coli expression systems with His-tags for simplified purification and standardized protocols .
Optimizing expression of membrane proteins like frdC requires specific strategies to address challenges related to their hydrophobic nature:
Strain Selection and Vector Design:
Use specialized E. coli strains (C41/C43) engineered for membrane protein expression
Incorporate fusion partners that enhance solubility (SUMO, MBP) alongside purification tags
Consider codon optimization for the expression host
Expression Conditions Optimization Matrix:
| Parameter | Range to Test | Effect on Expression |
|---|---|---|
| Temperature | 16-30°C | Lower temperatures reduce inclusion body formation |
| Inducer Concentration | 0.1-1.0 mM IPTG | Lower concentrations may improve folding |
| Media Composition | LB, TB, 2YT | Rich media often improves yield |
| Growth Phase | OD600 0.4-0.8 | Early induction may reduce toxicity |
| Expression Duration | 4-24 hours | Extended time at lower temperatures may increase yield |
Membrane Extraction and Protein Solubilization:
Test multiple detergents (DDM, CHAPS, Triton X-100) for optimal solubilization
Implement a stepwise solubilization protocol with increasing detergent concentrations
Include stabilizing agents like glycerol (5-50%) in buffers as indicated in product specifications
Purification Strategy:
Affinity chromatography (IMAC for His-tagged proteins)
Size exclusion chromatography to remove aggregates
Consider on-column refolding for proteins recovered from inclusion bodies
Quality Control:
Circular dichroism to assess secondary structure
Thermal shift assays to evaluate stability
Functional reconstitution assays to confirm activity
Implementing these methodologies can significantly enhance both yield and quality of recombinant frdC protein for downstream applications.
Studying frdC functionality presents several methodological challenges due to its nature as a membrane-bound component of a multi-subunit complex:
Challenges with Isolated frdC:
Lacks intrinsic enzymatic activity when separated from catalytic subunits
Requires detergent solubilization, which may affect native conformation
Difficult to establish functional assays that directly measure isolated frdC activity
Experimental Approaches:
Reconstitution Strategies:
Co-expression of all four subunits (frdABCD) followed by complex purification
Stepwise reconstitution by combining individually purified subunits
Incorporation into proteoliposomes to mimic membrane environment
Functional Assessment Methods:
Enzyme activity assays measuring fumarate reduction or succinate oxidation
Electron transfer measurements using artificial electron donors/acceptors
Membrane potential measurements in reconstituted proteoliposomes
Protein-Protein Interaction Analysis:
Pull-down assays to verify subunit interactions
Surface plasmon resonance to measure binding kinetics
Cross-linking followed by mass spectrometry to identify interaction sites
The methodological challenge lies in distinguishing between the structural role of frdC (membrane anchoring) and potential effects on the catalytic activity of the complex, requiring carefully designed experiments that isolate specific functions.
Investigating the impact of frdC mutations on virulence requires systematic experimental approaches:
Mutation Generation Strategies:
Targeted Mutagenesis:
Site-directed mutagenesis for specific amino acid changes
Deletion mutants (complete or partial gene deletion)
Insertion mutants (transposon-based or recombineering)
Complementation Controls:
Wild-type gene reintroduction on plasmids
Chromosomal restoration using allelic exchange
Expression under native vs. constitutive promoters
Experimental Models for Virulence Assessment:
| Model Type | Measurements | Advantages |
|---|---|---|
| In vitro Cell Culture | Invasion rates, intracellular survival, cytokine induction | Controlled conditions, mechanistic insights |
| Chicken Infection | Mortality rates, bacterial loads in tissues, clinical signs | Most relevant host for S. gallinarum |
| Organ Culture Ex Vivo | Bacterial replication, tissue damage | Intermediate complexity system |
Research Findings:
Studies have demonstrated that mutations affecting anaerobic respiration genes, including fumarate reductase, attenuate Salmonella gallinarum virulence in chicken models. The greatest degree of attenuation was observed with mutations affecting nitrate reductase (napA, narG) with additional attenuations induced by a mutation affecting fumarate reductase (frdA) .
Analyzing subunit interactions within the fumarate reductase complex requires a multi-technique approach:
Structural Biology Methods:
X-ray crystallography of the entire complex
Cryo-electron microscopy for 3D structure determination
Hydrogen-deuterium exchange mass spectrometry to identify interaction surfaces
Biochemical Interaction Assays:
Co-purification approaches:
Tandem affinity purification with tags on different subunits
Pull-down assays with immobilized individual subunits
Blue native PAGE to analyze intact membrane protein complexes
Cross-linking strategies:
Chemical cross-linking followed by mass spectrometry
Photo-affinity labeling at specific residues
Site-specific crosslinkers to map interaction domains
Biophysical Techniques:
Förster resonance energy transfer (FRET) between labeled subunits
Surface plasmon resonance for binding kinetics determination
Isothermal titration calorimetry for thermodynamic parameters
Functional Interaction Analysis:
Activity assays with reconstituted complexes containing wild-type or mutated subunits
Comparative enzyme kinetics to assess effects of subunit modifications
Electron transfer measurements to evaluate coupling efficiency
Research has demonstrated that frdC forms a complex with frdD to create the membrane anchor for the catalytic subunits (frdA and frdB) . In E. coli, it has been shown that excess production of these membrane proteins leads to the formation of intracellular tubular structures, indicating the importance of controlled expression for proper membrane integration and complex assembly .
The expression of frdC is highly regulated by oxygen availability, requiring specialized methods to accurately analyze its dynamic regulation:
Experimental Systems for Oxygen Control:
Continuous culture systems:
Bioreactors with dissolved oxygen monitoring and control
Chemostat cultures with defined oxygen input rates
Gradient plates for spatial analysis of oxygen effects
Batch culture approaches:
Anaerobic chambers with controlled gas composition
Sealed vessels with oxygen-scavenging systems
Microaerobic conditions using CampyGen or similar systems
Expression Analysis Techniques:
| Technique | Application | Sensitivity |
|---|---|---|
| qRT-PCR | Targeted mRNA quantification | High for specific genes |
| RNA-Seq | Genome-wide transcription analysis | Medium-high, comprehensive |
| Western Blotting | Protein level analysis | Medium, antibody-dependent |
| Proteomics (LC-MS/MS) | Global protein abundance | High, but complex sample preparation |
| Reporter Systems | Real-time expression monitoring | High, requires genetic modification |
Key Regulatory Mechanisms:
The frdABCD operon is regulated by two cellular regulatory proteins, ArcA and Fnr, which respond to aerobic-anaerobic conditions and cellular growth rate . Under anaerobic conditions, expression levels increase more than 10-fold compared to aerobic conditions .
This regulation ensures that fumarate reductase is primarily expressed when needed for anaerobic respiration, while being repressed during aerobic growth when the reverse reaction (succinate dehydrogenase activity) is performed by a different enzyme complex.
The P FRD promoter of the frdABCD operon has been successfully used to drive expression of other genes under anaerobic conditions, demonstrating its utility as a tool for controlled anaerobic expression .
Examining frdC across Salmonella serovars provides insights into host adaptation and pathogenesis mechanisms:
Comparative Analysis Approaches:
Sequence-based methods:
Multiple sequence alignment across serovars
Phylogenetic analysis of evolutionary relationships
Identification of serovar-specific polymorphisms or modifications
Functional genomics:
Comparative transcriptomics under identical conditions
Promoter activity analysis across serovars
Regulatory network mapping for anaerobic genes
Experimental Comparison Methodologies:
Cross-complementation studies with frdC from different serovars
Chimeric protein construction to identify functional domains
Heterologous expression to assess differences in protein stability or membrane integration
Key Findings and Implications:
The amino acid sequence of frdC appears highly conserved across Salmonella serovars , with identical sequences observed in S. gallinarum, S. agona, and S. choleraesuis.
Host-specific adaptation might be related to:
The highly conserved nature of frdC suggests it performs a fundamental function across Salmonella serovars, with host specificity likely driven by other genetic factors or by differences in regulation and metabolic context.
Using structural information to develop inhibitors of fumarate reductase involves several methodological approaches:
Structural Elucidation Methods:
Protein structure determination:
X-ray crystallography of the complete fumarate reductase complex
Cryo-EM for high-resolution structural analysis
NMR studies for dynamic regions or smaller domains
In silico approaches:
Homology modeling based on related structures
Molecular dynamics simulations to identify flexible regions
Computational prediction of binding pockets
Drug Discovery Strategies:
| Approach | Methodology | Advantages |
|---|---|---|
| Virtual Screening | In silico screening of compound libraries against structural models | Rapid, cost-effective initial screening |
| Fragment-Based | Identification of small molecule fragments that bind to target sites | Efficient exploration of chemical space |
| Structure-Based Design | Rational design based on structural knowledge of binding sites | Target-specific compounds with optimized interactions |
Target Site Considerations:
Membrane interface targeting:
Compounds disrupting frdC-frdD interaction
Molecules affecting membrane integration
Agents that alter electron transfer from quinol
Subunit interface targeting:
Inhibitors blocking assembly of the complete complex
Compounds affecting conformational changes required for activity
Validation Methodologies:
Enzyme inhibition assays with purified complex
Bacterial growth inhibition under anaerobic conditions
Mutagenesis studies to confirm binding sites
Co-crystallization with inhibitors to verify binding mode
The development of fumarate reductase inhibitors offers potential for new antimicrobials with specific activity against pathogens dependent on anaerobic respiration during infection. Since fumarate reductase plays a crucial role in Salmonella gallinarum virulence , such inhibitors could represent a novel therapeutic strategy for fowl typhoid.
Developing vaccines based on recombinant frdC requires addressing several experimental considerations:
Antigen Design and Production:
Structural modifications:
Removal of hydrophobic transmembrane domains for improved solubility
Creation of fusion proteins with carrier molecules (e.g., flagellin)
Identification and isolation of immunodominant epitopes
Expression systems:
Selection of appropriate host for high-quality antigen production
Purification strategies maintaining conformational epitopes
Endotoxin removal for parenteral administration
Formulation and Delivery Considerations:
| Approach | Advantages | Challenges |
|---|---|---|
| Subunit Vaccine | Defined composition, safety | May require adjuvants, multiple doses |
| DNA Vaccine | In vivo expression, cellular immunity | Delivery efficiency, species limitations |
| Vector Vaccine | Mimics natural infection, strong immunity | Safety concerns, pre-existing immunity to vector |
| Attenuated Live Vaccine | Comprehensive immunity, single dose | Safety, stability, cold chain requirements |
Immunological Assessment:
Antibody titer measurements (ELISA, neutralization assays)
T-cell response evaluation (proliferation, cytokine production)
Mucosal immunity assessment (secretory IgA levels)
Protection Evaluation:
Challenge studies in appropriate animal models
Measurement of bacterial loads in tissues
Clinical symptom and mortality assessment
Histopathological evaluation of lesions
Recent Research Approaches:
A promising strategy involves using attenuated Salmonella gallinarum strains as vector vaccines. Research has demonstrated that recombinant S. gallinarum vectors expressing heterologous antigens can provide protection against multiple pathogens. For example, an attenuated S. gallinarum strain expressing APEC type I fimbriae (strain SG102) demonstrated significant protection against both APEC and S. gallinarum challenges .
This approach leverages the natural tropism of S. gallinarum while reducing its virulence, potentially providing a platform for delivering frdC or other antigens to stimulate robust immune responses.